Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.120 +0.050 (+1.23%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week ↗

December 11, 2023

If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to...

Via Talk Markets

Topics Artificial Intelligence

Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November ↗

December 06, 2023

The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions.

Via Talk Markets

Topics Artificial Intelligence

Looking Into Recursion Pharmaceuticals's Recent Short Interest ↗

December 06, 2023

Via Benzinga

November Recap: Top 9 Micro/Small Cap AI Stocks Up +53%, On Average ↗

December 03, 2023

The top 9 micro- and small-cap AI stocks advanced by 53%, on average, in November.

Via Talk Markets

Topics Artificial Intelligence

Hewlett Packard Enterprise Posts Upbeat Earnings, Joins Foot Locker, NetApp And Other Big Stocks Moving Higher On Wednesday ↗

November 29, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Wednesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) moved higher during Wednesday’s session following...

Via Benzinga

Topics Stocks

This Stock Could Soar by 120%, According to Wall Street ↗

November 22, 2023

Don't rush to buy shares just yet.

Via The Motley Fool

Recursion Pharmaceuticals: Q3 Earnings Insights ↗

November 09, 2023

Via Benzinga

Recursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters. ↗

November 26, 2023

Scaling up means having more power to bring to bear on core activities.

Via The Motley Fool

Topics Artificial Intelligence

2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth ↗

November 23, 2023

Small-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy.

Via InvestorPlace

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

November 22, 2023

Via The Motley Fool

Cathie Wood Just Made a Big Bet on Recursion Pharmaceuticals Stock. Will It Pay Off? ↗

November 21, 2023

Cathie Wood just gave the company a huge vote of confidence.

Via The Motley Fool

Unlocking AI investment opportunities in healthcare

November 16, 2023

AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities.

Via MarketBeat

Topics Artificial Intelligence ETFs

2 Risky Stocks With Massive Potential ↗

October 17, 2023

Neither is doing well this year.

Via The Motley Fool

Is Recursion Pharmaceuticals Stock a Buy Now? ↗

October 11, 2023

The company has grabbed plenty of headlines recently.

Via The Motley Fool

2 Cathie Wood Stocks I'm Bullish On ↗

October 05, 2023

These two next-gen biotechs could be outstanding buys for patient investors.

Via The Motley Fool

Cathie Wood Continues On Roku Shares Selling Spree After Company's Q3 Revenue Jump — Ark Sells $21.1M Of Stock ↗

November 13, 2023

Via Benzinga

AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence ↗

November 09, 2023

We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom that's greatly impacting healthcare.

Via InvestorPlace

Topics Artificial Intelligence

Bayer and Recursion Focus Research Collaboration on Oncology

November 09, 2023

Digitally enabled drug discovery for oncology has the potential to accelerate the delivery of new cancer therapies to patients. Drug discovery research collaboration may initiate up to seven oncology...

From Recursion Pharmaceuticals

Via GlobeNewswire

Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology

November 09, 2023

With additional patient-centric data, compute power, and an exciting new focus for its Bayer collaboration, the company is accelerating the shift of biotech to techbio

From Recursion Pharmaceuticals, Inc.

Via GlobeNewswire

Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results

November 09, 2023

From Recursion Pharmaceuticals

Via GlobeNewswire

3 Stocks to Buy for Their Proximity to Nvidia ↗

November 08, 2023

Nvidia isn't the only AI stock on the market. These three companies stand to benefit from Nvidia's success while offering diversification.

Via InvestorPlace

Topics Artificial Intelligence

Recursion to Participate in Upcoming Investor Conference

November 02, 2023

From Recursion Pharmaceuticals

Via GlobeNewswire

The 7 Best Cathie Wood Stocks to Buy Now: November Edition ↗

November 01, 2023

Dive into the dynamic world of Cathie Wood stocks, wagering on the disruptive tech gems shaping tomorrow's investment landscape.

Via InvestorPlace

Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

November 03, 2023

Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740.

Via Benzinga

2 Reasons to Buy Recursion Pharmaceuticals, and 1 Reason to Sell ↗

October 31, 2023

Pioneering businesses tend to carry big risks, but also the potential for big rewards.

Via The Motley Fool

3 Extra-Speculative Stocks That Could Make You Very, Very Rich ↗

October 26, 2023

Speculative stocks are a growth investor's dream—potential for untold riches, if you can find the stocks that will survive.

Via InvestorPlace

1 Artificial Intelligence Stock to Buy Hand Over Fist in October and 1 to Avoid ↗

October 13, 2023

One of these players could win in AI -- and in the healthcare market, in general.

Via The Motley Fool

Topics Artificial Intelligence

2 AI Stocks That Aren't Worth the Hype ↗

October 04, 2023

Even if you're bullish on AI, you may want to think twice about buying shares of these two companies.

Via The Motley Fool

Topics Artificial Intelligence

Cathie Wood's Ark Invest Sells Nearly $4M Worth Of NVIDIA Shares — Does It Herald Shift To Undervalued AI Gems? ↗

October 02, 2023

On Monday, Cathie Wood-led Ark Invest made a notable move by selling nearly $4 million worth of NVIDIA Corp (NASDAQ:NVDA) shares. This ...

Via Benzinga

Topics Artificial Intelligence

2 Cathie Wood Stocks That Could Deliver Exponential Returns ↗

October 02, 2023

These two cutting-edge healthcare companies could be significantly undervalued right now.

Via The Motley Fool

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.